We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’

By LabMedica International staff writers
Posted on 31 Oct 2024

Cardiovascular diseases (CVD) continue to be the leading cause of death globally, responsible for nearly one-third of all fatalities worldwide. More...

Traditionally, risk assessment for CVD has focused on well-established factors associated with atherosclerosis, such as demographics, lifestyle choices like smoking and physical activity, and health conditions including diabetes, hypertension, and obesity. Biomarkers, particularly non-HDL cholesterol, have also been crucial in identifying individuals at risk. Nonetheless, there remains a significant residual cardiovascular risk even after managing these known factors, indicating that additional, unexamined contributors to cardiovascular health may exist. In a new paper published in Aging, researchers have investigated how the integration of specific cardiovascular biomarkers could assist in evaluating this residual inflammatory risk, especially in the context of aging-related inflammation, known as "inflammaging."

The study, conducted by researchers from Marche Polytechnic University (UNIVPM, Ancona, Italy) and IRCCS INRCA (Ancona, Italy), focused on biomarkers such as high-sensitivity C-reactive protein (hs-CRP), high-sensitivity cardiac troponin (hs-cTn), and natriuretic peptides, which are valuable indicators of both inflammatory burden and early cardiovascular risk. The researchers propose a more comprehensive biomarker-based strategy for assessing cardiovascular risk that includes two distinct dimensions. The first set of biomarkers—comprising cytokines, immune cell phenotypes, and mediators released by senescent or dysfunctional cells, known as the senescence-associated secretory phenotype (SASP)—can indicate the overall burden of inflammaging and, by extension, residual inflammatory risk. The second set, which includes hs-cTn and natriuretic peptides (NPs), functions as surrogate markers that reflect the influence of inflammaging on organ function.

Importantly, the biomarkers in this second group can also serve as endpoints, as numerous studies have shown their responsiveness to therapeutic interventions. Establishing a mediating relationship between these two groups of biomarkers would enhance the understanding of the mechanistic connections between inflammaging and age-related organ dysfunction and disease. In summary, the researchers demonstrated that combining markers of chronic inflammation with cardiac health indicators provides a more comprehensive view of cardiovascular risk, highlighting the effects of aging-related inflammation, or "inflammaging," on heart health. They suggest that this approach could pave the way for targeted interventions in aging populations.


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Giardia Assay
AccuDiag Giardia
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.